TSE:TC

Tucows Competitors

C$96.34

-1.14 (-1.17 %)

(As of 05/14/2021 12:00 AM ET)

Add

Compare

Today's Range

C$95.41

▼

C$96.64

50-Day Range

C$92.31

▼

C$106.02

52-Week Range

C$73.65

▼

C$120.21

Volume5,955 shs

Average Volume4,428 shs

Market CapitalizationC$1.02 billion

P/E Ratio164.97

Dividend YieldN/A

BetaN/A

Tucows (TSE:TC) Vs. KXS, ENGH, DND, MAXR, DCBO, and AUP

Should you be buying TC stock or one of its competitors? Companies in the sector of "computer and technology" are considered alternatives and competitors to Tucows, including Kinaxis (KXS), Enghouse Systems (ENGH), Dye & Durham (DND), Maxar Technologies (MAXR), Docebo (DCBO), and Aurinia Pharmaceuticals (AUP).

Tucows vs. Kinaxis Stock

Tucows (TSE:TC) and Kinaxis (TSE:KXS) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for Tucows and Kinaxis, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tucows	0	0	1	0	3.00
Kinaxis	0	0	5	0	3.00

Tucows currently has a consensus price target of C$70.00, suggesting a potential downside of 27.34%. Kinaxis has a consensus price target of C$200.00, suggesting a potential upside of 43.43%. Given Kinaxis' higher probable upside, analysts plainly believe Kinaxis is more favorable than Tucows.

Valuation and Earnings

This table compares Tucows and Kinaxis' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tucows	C$298.09 million	3.43	C$6.20 million	C$0.58	164.97
Kinaxis	C$229.16 million	16.56	C$7.84 million	C$0.29	484.17

Kinaxis has lower revenue, but higher earnings than Tucows. Tucows is trading at a lower price-to-earnings ratio than Kinaxis, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Tucows and Kinaxis' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tucows	N/A	N/A	N/A
Kinaxis	N/A	N/A	N/A

Summary

Kinaxis beats Tucows on 5 of the 7 factors compared between the two stocks.

Tucows vs. Enghouse Systems Stock

Tucows (TSE:TC) and Enghouse Systems (TSE:ENGH) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for Tucows and Enghouse Systems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tucows	0	0	1	0	3.00
Enghouse Systems	0	0	1	0	3.00

Tucows currently has a consensus price target of C$70.00, suggesting a potential downside of 27.34%. Enghouse Systems has a consensus price target of C$74.75, suggesting a potential upside of 43.64%. Given Enghouse Systems' higher probable upside, analysts plainly believe Enghouse Systems is more favorable than Tucows.

Valuation and Earnings

This table compares Tucows and Enghouse Systems' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tucows	C$298.09 million	3.43	C$6.20 million	C$0.58	164.97
Enghouse Systems	C$512.22 million	5.64	C$102.54 million	C$1.85	28.16

Enghouse Systems has higher revenue and earnings than Tucows. Enghouse Systems is trading at a lower price-to-earnings ratio than Tucows, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Tucows and Enghouse Systems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tucows	N/A	N/A	N/A
Enghouse Systems	N/A	N/A	N/A

Summary

Enghouse Systems beats Tucows on 5 of the 6 factors compared between the two stocks.

Tucows vs. Dye & Durham Stock

Tucows (TSE:TC) and Dye & Durham (TSE:DND) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability.

Valuation and Earnings

This table compares Tucows and Dye & Durham's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tucows	C$298.09 million	3.43	C$6.20 million	C$0.58	164.97
Dye & Durham	C$87.04 million	32.56	C$-86,463,300.00	C($1.25)	-32.78

Tucows has higher revenue and earnings than Dye & Durham. Dye & Durham is trading at a lower price-to-earnings ratio than Tucows, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tucows and Dye & Durham, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tucows	0	0	1	0	3.00
Dye & Durham	0	2	3	0	2.60

Tucows currently has a consensus price target of C$70.00, suggesting a potential downside of 27.34%. Dye & Durham has a consensus price target of C$54.20, suggesting a potential upside of 31.87%. Given Dye & Durham's higher probable upside, analysts plainly believe Dye & Durham is more favorable than Tucows.

Profitability

This table compares Tucows and Dye & Durham's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tucows	N/A	N/A	N/A
Dye & Durham	N/A	N/A	N/A

Summary

Tucows beats Dye & Durham on 5 of the 8 factors compared between the two stocks.

Tucows vs. Maxar Technologies Stock

Maxar Technologies (TSE:MAXR) and Tucows (TSE:TC) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.

Profitability

This table compares Maxar Technologies and Tucows' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Maxar Technologies	N/A	N/A	N/A
Tucows	N/A	N/A	N/A

Valuation & Earnings

This table compares Maxar Technologies and Tucows' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maxar Technologies	C$1.73 billion	1.57	C$375.41 million	C$5.22	7.27
Tucows	C$298.09 million	3.43	C$6.20 million	C$0.58	164.97

Maxar Technologies has higher revenue and earnings than Tucows. Maxar Technologies is trading at a lower price-to-earnings ratio than Tucows, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Maxar Technologies and Tucows, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maxar Technologies	0	2	2	0	2.50
Tucows	0	0	1	0	3.00

Maxar Technologies currently has a consensus price target of C$53.00, indicating a potential upside of 39.55%. Tucows has a consensus price target of C$70.00, indicating a potential downside of 27.34%. Given Maxar Technologies' higher possible upside, equities analysts plainly believe Maxar Technologies is more favorable than Tucows.

Summary

Maxar Technologies beats Tucows on 5 of the 8 factors compared between the two stocks.

Tucows vs. Docebo Stock

Docebo (TSE:DCBO) and Tucows (TSE:TC) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.

Profitability

This table compares Docebo and Tucows' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Docebo	N/A	N/A	N/A
Tucows	N/A	N/A	N/A

Valuation & Earnings

This table compares Docebo and Tucows' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Docebo	C$62.92 million	30.13	C$-10,525,858.00	C($0.32)	-180.12
Tucows	C$298.09 million	3.43	C$6.20 million	C$0.58	164.97

Tucows has higher revenue and earnings than Docebo. Docebo is trading at a lower price-to-earnings ratio than Tucows, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Docebo and Tucows, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Docebo	0	1	5	0	2.83
Tucows	0	0	1	0	3.00

Docebo currently has a consensus price target of C$76.20, indicating a potential upside of 31.38%. Tucows has a consensus price target of C$70.00, indicating a potential downside of 27.34%. Given Docebo's higher possible upside, equities analysts plainly believe Docebo is more favorable than Tucows.

Summary

Tucows beats Docebo on 5 of the 8 factors compared between the two stocks.

Tucows vs. Aurinia Pharmaceuticals Stock

Aurinia Pharmaceuticals (TSE:AUP) and Tucows (TSE:TC) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.

Profitability

This table compares Aurinia Pharmaceuticals and Tucows' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Tucows	N/A	N/A	N/A

Valuation & Earnings

This table compares Aurinia Pharmaceuticals and Tucows' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$51.00 million	36.31	C$-162,117,340.00	C($1.27)	-11.42
Tucows	C$298.09 million	3.43	C$6.20 million	C$0.58	164.97

Tucows has higher revenue and earnings than Aurinia Pharmaceuticals. Aurinia Pharmaceuticals is trading at a lower price-to-earnings ratio than Tucows, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Aurinia Pharmaceuticals and Tucows, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0	0	2	0	3.00
Tucows	0	0	1	0	3.00

Aurinia Pharmaceuticals currently has a consensus price target of C$28.00, indicating a potential upside of 93.77%. Tucows has a consensus price target of C$70.00, indicating a potential downside of 27.34%. Given Aurinia Pharmaceuticals' higher possible upside, equities analysts plainly believe Aurinia Pharmaceuticals is more favorable than Tucows.

Summary

Tucows beats Aurinia Pharmaceuticals on 4 of the 7 factors compared between the two stocks.